Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -25.42% is 81% below its 5-year average of -14.05%, around the middle of its 5-year range (-93.58%–74.04%).
As of the fiscal period ended Tuesday, June 30, 2026. 690.26% below its 12-month average of -3.22%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -25.42%.
RETURN ON INVESTED CAPITAL (ROIC)
-25.42%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-3.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
13.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-14.05%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-24.45%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-690.26%
CURRENT VS 3Y AVG
-282.99%
CURRENT VS 5Y AVG
-80.95%
CURRENT VS 10Y AVG
-3.98%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.79%
median of 492 covered companies
CURRENT VS SECTOR MEDIAN
+11.69%
vs the sector median at left
CytomX Therapeutics, Inc.
Market Cap
$561.67M
Return on Invested Capital (ROIC)
-25.42%
TTM Avg
-3.22%
3Y Avg
13.89%
5Y Avg
-14.05%
Market Cap
$569.56M
Return on Invested Capital (ROIC)
27.87%
TTM Avg
-1.63%
3Y Avg
-31.88%
5Y Avg
-39.02%
Market Cap
$551.09M
Return on Invested Capital (ROIC)
-18.20%
TTM Avg
-95.31%
3Y Avg
-87.63%
5Y Avg
-71.60%
Market Cap
$573.38M
Return on Invested Capital (ROIC)
-45.62%
TTM Avg
-46.61%
3Y Avg
-61.97%
5Y Avg
-71.18%
Market Cap
$547.86M
Return on Invested Capital (ROIC)
-0.81%
TTM Avg
-8.59%
3Y Avg
-110.96%
5Y Avg
-102.03%
Market Cap
$579.88M
Return on Invested Capital (ROIC)
-43.41%
TTM Avg
-39.91%
3Y Avg
-39.91%
5Y Avg
-39.91%
Market Cap
$587.93M
Return on Invested Capital (ROIC)
-4.97%
TTM Avg
-6.49%
3Y Avg
-6.53%
5Y Avg
-6.86%
Market Cap
$596.36M
Return on Invested Capital (ROIC)
-56.99%
TTM Avg
-66.45%
3Y Avg
-57.50%
5Y Avg
-60.06%
Market Cap
$600.84M
Return on Invested Capital (ROIC)
58.60%
TTM Avg
17.42%
3Y Avg
-47.16%
5Y Avg
-23.48%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | $561.67M | -25.42% | -3.22% | 13.89% | -14.05% |
| CorMedix Inc. (CRMD)vs › | $569.56M | 27.87% | -1.63% | -31.88% | -39.02% |
| Immix Biopharma, Inc. (IMMX)vs › | $551.09M | -18.20% | -95.31% | -87.63% | -71.60% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $573.38M | -45.62% | -46.61% | -61.97% | -71.18% |
| Delcath Systems, Inc. (DCTH)vs › | $547.86M | -0.81% | -8.59% | -110.96% | -102.03% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $579.88M | -43.41% | -39.91% | -39.91% | -39.91% |
| OrthoPediatrics Corp. (KIDS)vs › | $587.93M | -4.97% | -6.49% | -6.53% | -6.86% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $596.36M | -56.99% | -66.45% | -57.50% | -60.06% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $600.84M | 58.60% | 17.42% | -47.16% | -23.48% |
| Altimmune, Inc. (ALT)vs › | $519.25M | -19.47% | -57.88% | -52.57% | -47.02% |
ROIC
-25.4%
ROE
-26.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -25.42% |
| 2026-03-31 | -19.70% |
| 2025-12-31 | -21.31% |
| 2025-09-30 | 18.76% |
| 2025-06-30 | 31.59% |
| 2025-03-31 | 74.04% |
| 2024-12-31 | 71.41% |
| 2024-09-30 | 31.20% |
| 2024-06-30 | 61.53% |
| 2024-03-31 | 37.80% |
| 2023-12-31 | 1.78% |
| 2023-09-30 | -9.97% |
| 2023-06-30 | -71.11% |
| 2023-03-31 | -89.87% |
| 2022-12-31 | -93.58% |
| 2022-09-30 | -91.83% |
| 2022-06-30 | -69.14% |
| 2022-03-31 | -51.64% |
| 2021-12-31 | -32.03% |
| 2021-09-30 | -26.62% |
| 2021-06-30 | -20.87% |
| 2021-03-31 | -18.28% |
| 2020-12-31 | -16.73% |
| 2020-09-30 | -26.07% |
| 2020-06-30 | -27.01% |
| 2020-03-31 | -29.37% |
| 2019-12-31 | -43.37% |
| 2019-09-30 | -33.51% |
| 2019-06-30 | -29.63% |
| 2019-03-31 | -22.63% |
| 2018-12-31 | -21.68% |
| 2018-09-30 | -13.45% |
| 2018-06-30 | -14.01% |
| 2018-03-31 | -17.37% |
| 2017-12-31 | -13.75% |
| 2017-09-30 | -18.76% |
| 2017-06-30 | -21.68% |
| 2017-03-31 | -36.96% |
| 2016-12-31 | -36.48% |
| 2016-09-30 | -33.62% |
| 2016-06-30 | -28.83% |
| 2016-03-31 | -25.45% |
| 2015-12-31 | -18.30% |
| 2015-09-30 | -23.77% |
| 2015-06-30 | -14.90% |
| 2015-03-31 | -30.61% |
| 2014-12-31 | -47.01% |
